Organigram Holdings Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.310
+0.020 (1.55%)
At close: Feb 21, 2025, 4:00 PM
1.320
+0.010 (0.73%)
After-hours: Feb 21, 2025, 7:54 PM EST
Organigram Holdings Market Cap
Organigram Holdings has a market cap or net worth of $161.71 million as of February 21, 2025. Its market cap has decreased by -6.47% in one year.
Market Cap
161.71M
Enterprise Value
160.26M
1-Year Change
-6.47%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since May 21, 2019, Organigram Holdings's market cap has decreased from $1.01B to $161.71M, a decrease of -84.07%. That is a compound annual growth rate of -27.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 165.30M | -5.43% |
| Dec 31, 2024 | 174.80M | 64.44% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.00B |
| UnitedHealth Group | 465.53B |
| Johnson & Johnson | 384.41B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.59B |
| Abbott Laboratories | 230.46B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.93B |